These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22915782)

  • 61. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
    Cheng N; Liu Y; Zhao G; Xu Y; Zhang T; Chen Y; Yan G; Hu Y; Yao S; Wang Z; Wang C; Chen Z; Hu Z; Liu D; Chen T
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):340-348. PubMed ID: 31655197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.
    Palma DA; Senan S; Oberije C; Belderbos J; de Dios NR; Bradley JD; Barriger RB; Moreno-Jiménez M; Kim TH; Ramella S; Everitt S; Rengan R; Marks LB; De Ruyck K; Warner A; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):690-6. PubMed ID: 24035329
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
    Wurstbauer K; Deutschmann H; Kranzinger M; Merz F; Rahim H; Sedlmayer F; Kogelnik HD
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):333-41. PubMed ID: 10760428
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiation esophagitis: Predictive factors and preventive strategies.
    Bradley J; Movsas B
    Semin Radiat Oncol; 2004 Oct; 14(4):280-6. PubMed ID: 15558501
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.
    Wurstbauer K; Merz F; Sedlmayer F
    Strahlenther Onkol; 2009 Aug; 185(8):512-6. PubMed ID: 19652934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluating the relationship between dosimetric parameters and esophagitis in patients who experienced radiotherapy in the cervicothoracic region.
    Siavashpour Z; Rabiee N; Bakhshandeh M; Anvari A; Zayeri F
    J Cancer Res Ther; 2022; 18(4):1009-1015. PubMed ID: 36149154
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
    Reboul FL
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
    Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
    Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy 
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment-related esophagitis.
    Werner-Wasik M
    Semin Oncol; 2005 Apr; 32(2 Suppl 3):S60-6. PubMed ID: 16015537
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.
    Kim JW; Kim TH; Kim JH; Lee IJ
    World J Gastroenterol; 2018 Feb; 24(7):862-869. PubMed ID: 29467556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.
    Dankers FJWM; Wijsman R; Troost EGC; Tissing-Tan CJA; Kwint MH; Belderbos J; de Ruysscher D; Hendriks LE; de Geus-Oei LF; Rodwell L; Dekker A; Monshouwer R; Hoffmann AL; Bussink J
    Radiother Oncol; 2018 Nov; 129(2):249-256. PubMed ID: 30241789
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non-small Cell Lung Cancer: The Final Report.
    Yoshimura N; Tada T; Matsumoto Y; Sawa K; Yoshimoto N; Suzumura T; Tanaka H; Mitsuoka S; Kimura T; Tamiya T; Hirashima T; Kawaguchi T; Kudoh S; Hosono M; Hirata K
    Am J Clin Oncol; 2018 Oct; 41(10):967-971. PubMed ID: 29045265
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute radiation oesophagitis associated with 2-deoxy-2-[18F]fluoro-d-glucose uptake on positron emission tomography/CT during chemo-radiation therapy in patients with non-small-cell lung cancer.
    Everitt S; Callahan J; Obeid E; Hicks RJ; Mac Manus M; Ball D
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):682-688. PubMed ID: 28608503
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy.
    De Ruyck K; Sabbe N; Oberije C; Vandecasteele K; Thas O; De Ruysscher D; Lambin P; Van Meerbeeck J; De Neve W; Thierens H
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):537-44. PubMed ID: 21605946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer.
    Uyterlinde W; Chen C; Kwint M; de Bois J; Vincent A; Sonke JJ; Belderbos J; van den Heuvel M
    Radiother Oncol; 2013 Jun; 107(3):392-7. PubMed ID: 23647749
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
    Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.